Doctor Marisa Nieto
Centre for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Valladolid (Spain)
Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.
Event: Heart Failure 2022
Topic: Experimental Heart Failure
Session: Heart Failure ePosters - focus on Chronic Heart Failure 6
ESC 365 is supported by
